Dr Katherine Ruzhansky previews presentations on biomarkers, new therapies, and translational science at AANEM 2025.

Insights from AANEM 2025, including anticipated presentations, key takeaways, and how emerging research in myasthenia gravis ...

Department of Pharmacy, Yantai Yuhuangding Hospital Affiliated to Qingdao University, Yantai, Shandong, China Objective: To integrate pharmacovigilance and network pharmacology methods for a ...

Background: Thymectomy is one of the main treatments for thymoma associated myasthenia gravis, but there is a risk of acute exacerbation of myasthenia gravis symptoms during the perioperative period ...

Emerging research suggests that myasthenia gravis (MG), an autoimmune neuromuscular disorder, is associated with alterations in the gut microbiome and reduced production of the short-chain fatty acid ...

MG patients reported higher anxiety during COVID-19 due to immunosuppressive treatment risks and potential symptom exacerbation. The study observed increased COVID-19 exposure among MG patients, but ...